Paul W. Hoelscher

Overview

Paul W. Hoelscher received an average of $6.2M in compensation at Horizon Pharma from 2014 to 2018.

Source: SEC filings on April 8, 2019, April 2, 2018, and April 3, 2017.

Related executives

We found 12 more executives who work or worked at Horizon Pharma.

Timothy Walbert

Horizon Pharma

Chief Executive Officer

Robert Carey

Horizon Pharma

Executive Vice President, Chief Business Officer

Shao-Lee Lin

Horizon Pharma

Chief Scientific Officer

Barry Moze

Horizon Pharma

Chief Administrative Officer

Irina Konstantinovsky

Horizon Pharma

Chief Human Resources Officer

David Happel

Horizon Pharma

Executive Vice President, Commercial Development and Strategy

John Kody

Horizon Pharma

Former Executive Vice President, Chief Commercial Officer

George Hampton

Horizon Pharma

Executive Vice President, Orphan and Primary Care Business Units and International Operations

News

You may also like